Exact Mass: 404.1366

Exact Mass Matches: 404.1366

Found 57 metabolites which its exact mass value is equals to given mass value 404.1366, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Bentiromide

(S)-4-((2-(Benzoylamino)-3-(4-hydroxyphenyl)-1-oxopropyl)amino)benzoic acid

C23H20N2O5 (404.1372)


Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada (It was withdrawn in the US in October 1996). V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CK - Tests for pancreatic function D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. The bentiromide test is an excellent means of confirming the diagnosis of pancreatic exocrine insufficiency by outpatient test of chymotrypsin function[1].

   

1,3-Benzodioxolane-5-carboxylicacid4'-benzyloxy-3'-methoxybenzylidenehydrazide

N-{[4-(benzyloxy)-3-methoxyphenyl]methylidene}-2H-1,3-benzodioxole-5-carbohydrazide

C23H20N2O5 (404.1372)


   

Ala Cys Asp Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Ala Cys Pro Asp

(2S)-2-{[(2S)-1-[(2R)-2-[(2S)-2-aminopropanamido]-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H24N4O7S (404.1366)


   

Ala Asp Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carboxypropanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Ala Asp Pro Cys

(3S)-3-[(2S)-2-aminopropanamido]-4-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O7S (404.1366)


   

Ala Pro Cys Asp

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]butanedioic acid

C15H24N4O7S (404.1366)


   

Ala Pro Asp Cys

(3S)-3-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}propanoic acid

C15H24N4O7S (404.1366)


   

Cys Ala Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Cys Ala Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H24N4O7S (404.1366)


   

Cys Asp Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carboxypropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Cys Asp Pro Ala

(3S)-3-[(2R)-2-amino-3-sulfanylpropanamido]-4-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O7S (404.1366)


   

Cys Glu Gly Pro

(2S)-1-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carboxybutanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Cys Glu Pro Gly

(4S)-4-[(2R)-2-amino-3-sulfanylpropanamido]-5-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O7S (404.1366)


   

Cys Gly Glu Pro

(2S)-1-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Cys Gly Pro Glu

(2S)-2-{[(2S)-1-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetyl}pyrrolidin-2-yl]formamido}pentanedioic acid

C15H24N4O7S (404.1366)


   

Cys Pro Ala Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]butanedioic acid

C15H24N4O7S (404.1366)


   

Cys Pro Asp Ala

(3S)-3-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-3-{[(1S)-1-carboxyethyl]carbamoyl}propanoic acid

C15H24N4O7S (404.1366)


   

Cys Pro Glu Gly

(4S)-4-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}-4-[(carboxymethyl)carbamoyl]butanoic acid

C15H24N4O7S (404.1366)


   

Cys Pro Gly Glu

(2S)-2-(2-{[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)pentanedioic acid

C15H24N4O7S (404.1366)


   

Asp Ala Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]propanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Asp Ala Pro Cys

(3S)-3-amino-3-{[(2S)-1-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C15H24N4O7S (404.1366)


   

Asp Cys Ala Pro

(2S)-1-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-sulfanylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Asp Cys Pro Ala

(3S)-3-amino-3-{[(2R)-1-[(2S)-2-{[(1S)-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]carbamoyl}propanoic acid

C15H24N4O7S (404.1366)


   

Asp Pro Ala Cys

(3S)-3-amino-4-[(2S)-2-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O7S (404.1366)


   

Asp Pro Cys Ala

(3S)-3-amino-4-[(2S)-2-{[(1R)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H24N4O7S (404.1366)


   

Glu Cys Gly Pro

(2S)-1-{2-[(2R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-sulfanylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Glu Cys Pro Gly

(4S)-4-amino-4-{[(2R)-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-1-oxo-3-sulfanylpropan-2-yl]carbamoyl}butanoic acid

C15H24N4O7S (404.1366)


   

Glu Gly Cys Pro

(2S)-1-[(2R)-2-{2-[(2S)-2-amino-4-carboxybutanamido]acetamido}-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Glu Gly Pro Cys

(4S)-4-amino-4-({2-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)butanoic acid

C15H24N4O7S (404.1366)


   

Glu Pro Cys Gly

(4S)-4-amino-5-[(2S)-2-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O7S (404.1366)


   

Glu Pro Gly Cys

(4S)-4-amino-5-[(2S)-2-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O7S (404.1366)


   

Gly Cys Glu Pro

(2S)-1-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Gly Cys Pro Glu

(2S)-2-{[(2S)-1-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C15H24N4O7S (404.1366)


   

Gly Glu Cys Pro

(2S)-1-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-carboxybutanamido]-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid

C15H24N4O7S (404.1366)


   

Gly Glu Pro Cys

(4S)-4-(2-aminoacetamido)-5-[(2S)-2-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C15H24N4O7S (404.1366)


   

Gly Pro Cys Glu

(2S)-2-[(2R)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]pentanedioic acid

C15H24N4O7S (404.1366)


   

Gly Pro Glu Cys

(4S)-4-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}butanoic acid

C15H24N4O7S (404.1366)


   

Pro Ala Cys Asp

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-sulfanylpropanamido]butanedioic acid

C15H24N4O7S (404.1366)


   

Pro Ala Asp Cys

(3S)-3-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-3-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanoic acid

C15H24N4O7S (404.1366)


   

Pro Cys Ala Asp

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]butanedioic acid

C15H24N4O7S (404.1366)


   

Pro Cys Asp Ala

(3S)-3-{[(1S)-1-carboxyethyl]carbamoyl}-3-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanoic acid

C15H24N4O7S (404.1366)


   

Pro Cys Glu Gly

(4S)-4-[(carboxymethyl)carbamoyl]-4-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]butanoic acid

C15H24N4O7S (404.1366)


   

Pro Cys Gly Glu

(2S)-2-{2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]acetamido}pentanedioic acid

C15H24N4O7S (404.1366)


   

Pro Asp Ala Cys

(3S)-3-{[(1S)-1-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H24N4O7S (404.1366)


   

Pro Asp Cys Ala

(3S)-3-{[(1R)-1-{[(1S)-1-carboxyethyl]carbamoyl}-2-sulfanylethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H24N4O7S (404.1366)


   

Pro Glu Cys Gly

(4S)-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C15H24N4O7S (404.1366)


   

Pro Glu Gly Cys

(4S)-4-[({[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}methyl)carbamoyl]-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C15H24N4O7S (404.1366)


   

Pro Gly Cys Glu

(2S)-2-[(2R)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}-3-sulfanylpropanamido]pentanedioic acid

C15H24N4O7S (404.1366)


   

Pro Gly Glu Cys

(4S)-4-{[(1R)-1-carboxy-2-sulfanylethyl]carbamoyl}-4-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanoic acid

C15H24N4O7S (404.1366)


   

Bentiromide

Bentiromide [USAN:BAN:INN:JAN];Bentiromido [INN-Spanish];Bentiromidum [INN-Latin];BTPABA;PFT

C23H20N2O5 (404.1372)


V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CK - Tests for pancreatic function D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. The bentiromide test is an excellent means of confirming the diagnosis of pancreatic exocrine insufficiency by outpatient test of chymotrypsin function[1].

   

Ruxolitinib phosphate

Ruxolitinib phosphate

C17H21N6O4P (404.1362)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Deuruxolitinib phosphate

Deuruxolitinib phosphate

C17H21N6O4P (404.1362)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C125450 - JAK2 Inhibitor

   

1,3-Benzodioxolane-5-carboxylic acid 4-benzyloxy-3-methoxybenzylidene hydrazide

N-[(3-methoxy-4-phenylmethoxyphenyl)methylideneamino]-1,3-benzodioxole-5-carboxamide

C23H20N2O5 (404.1372)


   

N-Benzoyl-L-tyrosyl-p-aminobenzoic acid

N-Benzoyl-L-tyrosyl-p-aminobenzoic acid

C23H20N2O5 (404.1372)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents

   

3-[(2E)-2-[(4-Benzoyloxy-3-ethoxyphenyl)methylidene]hydrazinyl]benzoic acid

3-[(2E)-2-[(4-Benzoyloxy-3-ethoxyphenyl)methylidene]hydrazinyl]benzoic acid

C23H20N2O5 (404.1372)


   

N-[(3-methoxy-4-phenylmethoxyphenyl)methylideneamino]-1,3-benzodioxole-5-carboxamide

N-[(3-methoxy-4-phenylmethoxyphenyl)methylideneamino]-1,3-benzodioxole-5-carboxamide

C23H20N2O5 (404.1372)